Currently Enrolling

We’re conducting clinical research in depression to learn how individuals’ brain biology impacts response to treatment, with the goal to help people find relief faster. 

Are you feeling sad, down or unmotivated? Taking antidepressant medication but still experiencing symptoms? You may be eligible for our clinic’s research studies aimed at improving mental health.

Audience: Online – Anywhere in the United States

Duration & compensation: $765 – For Completion of Study

Email: Study@StarlightClinicalResearch

Phone: (970) 420-5804

Starlight Clinical Research is focused on novel research that may impact your well-being. We welcome a broad range of research topics including:

Post Traumatic Stress Disorder – PTSD

Substance Use Disorder – SUD

Generalized Anxiety Disorder – GAD

Major Depressive Disorder – MDD

Treatment Resistant Depression – TRD

Obsessive Compulsive Disorder – OCD

Postpartum Depression – PPD

Attention-Deficit/Hyperactivity Disorder – ADHD

Autism Spectrum Disorder – ASD

Chronic Pain

Migraines

Smoking Cessation

Women’s Health

Psychedelic Medicine Studies

Diversity, Equity, Inclusion and Belonging

At the core of our commitment to fostering a supportive environment is the principle of inclusivity. We firmly believe that clinical research should be accessible to everyone, irrespective of race, gender, sexual orientation, or identity. Every individual is welcomed and will be considered for enrollment in our clinical research programs, embracing the rich diversity of our community.

We recognize that diversity in clinical research is not just a matter of principle, but also a critical factor in achieving a more accurate and comprehensive understanding of efficacy. By ensuring a wide range of participants, our research reflects the varied needs and responses of a diverse population, leading to more effective and inclusive medical advancements.

Understanding Clinical Trials

Clinical trials play a crucial role in the advancement of medical science and the development of new medications. Essentially, these trials are research studies where volunteers participate to receive investigational treatments. These treatments are carefully monitored under the supervision of qualified physicians and research professionals.

Developed by pharmaceutical and biotechnology companies, these investigational drugs are part of a meticulous process to evaluate their benefits and effectiveness. Physicians, known as investigators, are selected based on their qualifications to lead these trials. Their expertise is vital in ensuring the integrity and success of the study.

Typically, clinical trials are conducted in four phases. The pre-marketing stages are Phase I, II, and III. Phase I trials generally involve a smaller group of people and focus primarily on assessing the safety of a drug. As the phases progress, the number of participants increases, with later phases broadening the scope to evaluate the effectiveness and further safety aspects of the medication.

Following these, there’s a post-marketing phase, known as Phase IV, which occurs after the drug has been approved for public use. This phase continues to monitor the drug’s performance and long-term effects in a wider population.

Each phase plays a distinct and vital role in the journey of a drug from its initial development to its availability to patients. Through clinical trials, we can ensure that new treatments are not only effective but also safe for public use, paving the way for medical breakthroughs and the enhancement of healthcare.

Exploring the Phases of a Clinical Trial

Clinical trials are divided into distinct phases, each with its specific goals and characteristics, vital to the development and approval of new drugs and devices.

Phase I: The primary focus is to evaluate the safety of a new drug or device. Conducted over several months, this phase typically involves 20 to 100 healthy volunteers. Participants may receive compensation for their involvement. The key objectives are to understand how the drug or device is processed in the body and to identify any side effects, particularly at varying dosage levels. Approximately 70% of experimental drugs proceed past this phase.

Phase II: This phase aims to assess the efficacy of the drug or device. Lasting from several months to two years, it involves several hundred patients. Phase II often employs randomized trials, where one group receives the experimental drug and a control group receives a standard treatment or placebo. Blinding is common, meaning neither the participants nor the researchers know who received treatment or a placebo. This method provides valuable comparative data on the safety and effectiveness of the drug. About one-third of experimental drugs successfully complete both Phase I and Phase II.

Phase III: Involving several hundred to several thousand patients, this phase extends for several years, offering comprehensive data on the drug or device’s effectiveness, benefits, and potential adverse reactions. It’s a crucial phase before seeking FDA approval, with 70 to 90% of drugs successfully completing this stage.

Phase IV: Conducted post-approval, these studies, also known as Post Marketing Surveillance Trials, have various objectives. They compare the new drug with existing market options, monitor long-term effectiveness and impact on quality of life, and assess cost-effectiveness. Findings in this phase can lead to a drug being withdrawn from the market or restrictions on its use.

At Starlight Clinical Research, our focus primarily lies in conducting Phase II and Phase III studies. These phases are pivotal in determining the efficacy and safety of new treatments, ensuring that they meet the stringent requirements for market approval and contribute significantly to advancing medical science and patient care.

Deciding to Participate in Clinical Research

Participating in clinical research is a personal decision that comes with various benefits and considerations. Understanding why and how to participate can guide you in making an informed choice.

Reasons for Participation: Volunteers in phase II and III clinical trials often have access to new, promising drugs well before they are available on the market. This can be an attractive option for those seeking advanced treatments.

Protection of Rights and Safety: The safety and rights of participants are safeguarded in two key ways:

  • Institutional Review Board (IRB) Approval: Before a study begins, it must receive approval from an IRB. This board, typically comprising both medical professionals and laypeople, ensures that the study’s protocol protects the rights of participants and does not expose them to unnecessary risks.
  • Informed Consent: Participants in U.S. clinical trials are required to sign an informed consent form. This document explains the study’s nature, potential risks, and the participant’s rights, including the freedom to withdraw from the study at any time.

Making an Informed Decision: If you’re considering joining a clinical trial, it’s essential to discuss this with your healthcare providers. Understanding the credentials and experience of the team conducting the study, as well as the facilities involved, is crucial. This conversation can help you weigh the potential benefits against the risks and responsibilities involved in participating in clinical research.

At Starlight Clinical Research, we encourage potential participants to thoroughly understand the scope and nature of the research, ensuring that their participation is based on a well-informed and considered decision. Your wellbeing and informed consent are our top priorities in the pursuit of advancing medical knowledge and treatments.

What Questions Should I Ask Before Participating?

When considering participation in a clinical trial, it’s crucial to gather as much information as possible to make an informed decision. Here are some key questions to ask, along with additional relevant inquiries:

  • Duration and Schedule: How long will the trial last? What is the frequency and duration of the treatment sessions or visits?
  • Treatment Details: What treatments will be used? Are they new or already in use for other conditions?
  • Purpose of the Trial: What is the main objective of the trial? What specific questions is the trial designed to address?
  • Safety Monitoring: How will patient safety be monitored throughout the trial? What procedures are in place in case of an adverse reaction?
  • Risks and Benefits: What are the potential risks and side effects? What are the possible benefits, both for me and for medical research?
  • Alternative Treatments: Are there alternate treatments already available for my condition? How do they compare to the treatment being studied?
  • Response to Harm: What happens if I am harmed by the trial? What kind of support or treatment will be provided?
  • Post-Trial Treatment: Can I opt to remain on this treatment even after the study ends?
  • Compensation: Will I be compensated for my time and expenses? How does the compensation structure work?
  • Withdrawal from the Trial: What if I want to stop participating in the trial? Are there any consequences or follow-up procedures?

Additional Relevant Questions:

  • Privacy and Confidentiality: How will my privacy and personal medical information be protected?
  • Follow-up Care: Is there any follow-up care after the trial ends? Who will be responsible for my care post-trial?
  • Study Sponsor: Who is funding or sponsoring the trial, and what is their role?
  • Eligibility Criteria: What are the inclusion and exclusion criteria for the trial? How do these criteria affect my participation?
  • Study Results: How will the results of the trial be communicated to me? Will I have access to overall study findings?
  • Emergency Contact: Who should I contact in case of an emergency related to the trial?
  • Trial Protocol: Can I review the full trial protocol or summary document?

Asking these questions can provide a clearer understanding of what participation entails, helping you to weigh the benefits and risks before making a commitment. Remember, your informed consent is paramount, and you have the right to receive comprehensive and clear answers to all your questions.

A Guide to Clinical Trial Opportunities at Starlight Clinical Research

Starlight Clinical Research specializes in a diverse range of clinical trials, with a primary focus on psychedelic medicine. Here’s an overview of the types of clinical trials we engage in, detailed in easy-to-read bullet points:

  • Focus on Psychedelic Medicine: We are equipped for trials in psychedelic medicine, catering to the unique requirements of such studies.
  • Wide Range of Conditions: Our trials cover various conditions, including but not limited to:
    • Post-Traumatic Stress Disorder (PTSD)
    • Generalized Anxiety Disorder (GAD)
    • Major Depressive Disorder (MDD)
    • Treatment-Resistant Depression (TRD)
    • Obsessive-Compulsive Disorder (OCD)
    • Postpartum Depression (PPD)
    • Substance Use Disorders (SUD)
    • Autism Spectrum Disorders
    • Chronic Pain
    • Migraine Headaches
    • Smoking Cessation
    • Women’s Health Issues
    • High-altitude Studies
  • Expertise in Multiple Disciplines: Our primary investigators are board-certified in key medical areas:
    • Internal Medicine
    • Psychiatry
    • Infectious Disease
  • Broad Research Topics: This diverse expertise allows us to cover a broad spectrum of research topics.
  • Open to Communication: We encourage potential participants to contact us to discuss possible involvement.
  • Future Opportunities: If we don’t currently have a study that fits your needs, we may have relevant opportunities in the future.
  • Personalized Approach: We maintain a database of interested individuals and actively seek out studies that match your needs and interests.

At Starlight Clinical Research, we believe in creating opportunities for participation in groundbreaking research. Whether you’re looking for current trials or future possibilities, we’re here to explore the right fit for you. Reach out to us to start a conversation about your participation in advancing medical science.

Participant Responsibilities at Starlight Clinical Research

Participation in a clinical trial at Starlight Clinical Research is a partnership where your role is vital for the success of the study. Here’s what we ask from you as a participant:

  • Timeliness for Appointments: Your punctuality for screening appointments is crucial. We aim to complete all screening requirements efficiently during your first visit. The duration of these screenings varies based on the specific needs of each study. Your on-time arrival assists us in maintaining our schedule and benefits both you and other participants. If you arrive early, we have a comfortable waiting area for your convenience.
  • Communication is Key: If you cannot make it to a scheduled screening appointment, we request that you inform us promptly. Our team will assist you in rescheduling your appointment smoothly.
  • Withdrawal from a Study: You have the right to withdraw from the study at any stage – during the screening process, any follow-up visits, or even at the final follow-up. If you decide to withdraw, especially during the recruitment phase, we appreciate prompt communication. This allows us to manage our studies effectively and offer the opportunity to another potential participant.

Your cooperation and communication are essential in helping us conduct our research efficiently and effectively. Thank you for your commitment to advancing medical science with us.

Understanding the Screening Process at Starlight Clinical Research

Embarking on a clinical trial begins with a comprehensive screening process. Here’s what you can expect:

  • Initial Pre-Screening:
    • A staff member will conduct an initial pre-screening, where you’ll be asked about your medical history.
    • We’ll discuss the specific criteria and guidelines of the study to see if it aligns with your profile.
  • Scheduling the Screening Visit:
    • If there’s mutual agreement to proceed, we’ll schedule your screening visit.
  • Informed Consent Review:
    • During your visit, you’ll receive an informed consent form. This document outlines the study’s design, potential risks and benefits, your responsibilities, visit schedule, and remuneration details.
    • You’ll have the opportunity to ask questions to fully understand the study and your role in it.
    • After thorough discussion and understanding, and once you consent, we’ll proceed with the study requirements.
  • Medical Assessments:
    • The screening typically includes collecting samples (like blood and urine), checking your vitals, and conducting an ECG.
    • You’ll have a meeting with one of our investigators to discuss your health and experiences in more detail.
    • Honesty and completeness in your responses are crucial for accurate assessment.
  • Bringing Your Medical Information:
    • Please bring any relevant medical information to the screening. This helps us in evaluating your suitability for the study accurately.
  • Additional Requirements:
    • Depending on the study, there may be other specific requirements and procedures to complete.
  • Post-Screening Process:
    • After the screening, we’ll provide remuneration as outlined in the informed consent.
    • We keep in touch to inform you about the results of the screening and whether you meet the study criteria.
    • Finally, after a collaborative decision making process with the study sponsor, we will inform you if you are selected to participate in the study.

Our goal is to ensure that you are well-informed and comfortable throughout the screening process. Your understanding and cooperation are key to a successful and ethical research study.

Diversity in Clinical Research: A Welcoming Statement from Starlight Clinical Research

At Starlight Clinical Research, we believe that diversity is not just a goal, it’s our strength. Our commitment to embracing diversity in our clinical research is rooted in the understanding that medical advancements benefit everyone when they reflect the rich tapestry of human experiences and backgrounds.

Why is Diversity Essential in Clinical Research?

  • Enhanced Quality of Research: Diversity in clinical research ensures that the results are applicable to a wider population. Different genetic makeups, lifestyles, and environments can affect how individuals respond to treatments. By including participants from varied backgrounds, we can gain a comprehensive understanding of the effectiveness and safety of medical interventions.
  • Equitable Healthcare: Historically, certain groups have been underrepresented in clinical research, leading to gaps in knowledge about how treatments work in these populations. At Starlight Clinical Research, we strive to rectify this imbalance, ensuring that all communities have a voice in research and access to the latest medical advancements.
  • Innovation Through Inclusivity: Diverse perspectives foster innovation. By welcoming participants from different ethnicities, ages, genders, socioeconomic statuses, and health backgrounds, we open the door to discoveries that may not emerge in a more homogenous study group.
  • Building Trust: Engaging with diverse communities in clinical research helps build trust and breaks down barriers to participation. Understanding and respecting cultural differences and values are paramount in our approach.

At Starlight Clinical Research, Your Participation Makes a Difference.

We warmly invite individuals from all walks of life to join our research studies. Your unique experiences and perspectives are invaluable in helping us shape the future of healthcare. Together, we can ensure that medical advancements are effective for and reflective of our diverse society.

Everyone is welcome here. Your health, your story, your diversity – they are the stars that guide us at Starlight Clinical Research.

Additional Resources